Emea Cell Counting Market Research Report – Regional Forecast till 2023
ID: MRFR/LS/0160-HCRR | October, 2018 | Region: Global | 90 pages | Half-Cooked Research Reports
EMEA Cell Counting Market Research Report: By Product (Spectrophotometers, Flow Cytometers, Microplates) Application (Hematologic, Microbiology) By End Users (Hospitals & Clinics, Research Organizations, Academic Institutes) – Regional Forecast till 2023
Market Scenario:
Cell counting is used for the quantification of cells in life sciences. Cell counting is important for research and serves as one of the major steps in a majority of experiments. It is effectively utilized for maintaining cell cultures. Moreover, another important application of cell counting can be seen in the diagnosis of chronic diseases like cancer. For instance, increase in the number of white blood cells (WBC) may indicate the possibility of cancerous growth in the body. Thus, cell counting is important for microbiology, hematologic and other medical specialties. Rising prevalence of chronic diseases like cancer, TB (tuberculosis), AIDS along with increasing healthcare sector is driving the growth of this market. According to the World Health Organization, cancer was the second leading cause of death across the globe in 2015 and caused around 8.8 million deaths globally. Moreover, it was estimated that more than 70% of the deaths due to cancer was caused in the middle and low-income countries. Moreover, increasing biotechnology industries and growing pharmaceutical sector is fuelling the market growth during the forecast period. In 2017, according to the Biotechnology and Biological Sciences Research Council (BBSRC), the European industrial biotechnology industry is expected to reach approximately USD 53.2 billion by 2030 from 28 billion in 2013. However, lack of skilled professionals and the high cost of the cell counting equipment may restrain the market growth during the forecast period, 2017-2023.
The EMEA cell counting market is expected to grow at an approximate CAGR of 8.6% during the forecast period.
Intended Audience
- Pharmaceutical companies
- Biotechnological institutes
- Research and Development (R&D) Companies
- Medical Research Laboratories
- Market Research and Consulting Service Providers
Figure 1:- EMEA cell counting market share, by region
Sources: WHO, annual reports, press release, white paper, and company presentation
Segmentation
The EMEA cell counting market is segmented on the basis of product, application, and end users.
On the basis of the product, the market is segmented into instruments, consumables & accessories, and others. The instrument segment is sub-segmented into spectrophotometers, flow cytometers, hematology analyzers, cell counters, and others. The consumables & accessories segment is sub-segmented into reagents, microplates, and others.
On the basis of the application, the market is segmented into hematology, microbiology, and others.
On the basis of the end users, the market is segmented into hospitals & clinics, research organizations, academic institutes, and others.
Regional Analysis
Europe is the largest EMEA cell counting market. Rising government support for research and a well-developed healthcare infrastructure within the region is driving the market growth within the region. This along with a huge patient population and growing healthcare expenditure is fuelling the market growth. According to the Cancer Research UK in 2014, about 356,860 new cases of cancer were reported within the region. Moreover, the total estimated deaths due to the same in 2014 were about 163,444.
Asia Pacific is the fastest growing region in the EMEA cell counting market. Presence of a huge patient population and continuously developing economies like India and China within the region drive the market growth. According to the Indian Brand Equity Foundation in 2017, the Indian healthcare sector is one of the fastest growing industries and is expected to advance at a CAGR of 22.8% and reach USD 280 billion by 2020. Moreover, according to the National Institute of Cancer Prevention and Research in 2017, about 2.5 million people are living with cancer. Additionally, favorable government policies like reduced excise and customs duty followed by the exemptions in service tax boost the market growth. Additionally, increasing healthcare expenditures fuels the market within the region.
On the other hand, the Middle East & Africa holds the least share in the EMEA cell counting market due to the presence of poor economy, especially within the African region. Moreover, the absence of developed healthcare sector and stringent government policies are expected to restrain the market growth within the region. Majority of the market within the region is held by the Middle East due to huge healthcare expenditures and presence of developed economies like Kuwait, Saudi Arabia, Dubai, and Qatar.
Research Methodology
Sources: WHO, annual reports, press release, white paper, and company presentation
Key players for EMEA cell counting market
Bio-Rad Laboratories Inc. (U.S.), General Electric Company (U.S.), Agilent Technologies (U.S.), PerkinElmer Inc. (U.S.), Tecan Trading AG (Switzerland), BioTek Instruments, Inc. (U.S.), Danaher (U.S.), and Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), and others are some of the key players for the EMEA cell counting market.
TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. EMEA Cell Counting Market, by Product
6.1 Introduction
6.2 Instruments
Market Estimates & Forecast, 2017 – 2023
6.2.1 Spectrophotometers
6.2.2 Flow Cytometers
6.2.3 Hematology Analyzers
6.2.4 Cell Counters
6.2.5 Others
6.3 Consumables & Accessories
Market Estimates & Forecast, 2017 – 2023
6.3.1 Reagents
6.3.2 Microplates
6.3.3 Others
6.3.4 Others
Chapter 7. EMEA Cell Counting Market, by Application
7.1 Introduction
7.2 Hematology
Market Estimates & Forecast, 2017 – 2023
7.3 Microbiology
Market Estimates & Forecast, 2017 – 2023
7.4 Others
Chapter 8. EMEA Cell Counting Market, by End Users
8.1 Introduction
8.2 Hospitals & Clinics
Market Estimates & Forecast, 2017 – 2023
8.3 Research Organizations
Market Estimates & Forecast, 2017 – 2023
8.4 Academic Institutes
Market Estimates & Forecast, 2017 – 2023
8.5 Others
Chapter 9. EMEA Cell Counting Market, by Region
9.1 Introduction
9.2 America
9.2.1 North America
9.2.1.1 US
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 U.K
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Republic of Korea
9.4.6 Rest of Asia Pacific
9.5 The Middle East & Africa
9.5.1 United Arab Emirates
9.5.2 Saudi Arabia
9.5.3 Oman
9.5.4 Kuwait
9.5.5 Qatar
9.5.6 Rest of the Middle East & Africa
Chapter 10. Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
10.3.1 Key Developments
Chapter 11 Company Profiles
11.1 Bio-Rad Laboratories Inc.
11.1.1 Company Overview
11.1.2 Product Overview
11.1.3 Financials
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.2 General Electric Company
11.2.1 Company Overview
11.2.2 Product Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Agilent Technologies
11.3.1 Company Overview
11.3.2 Product Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 PerkinElmer Inc.
11.4.1 Company Overview
11.4.2 Product/Business Segment Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 Tecan Trading AG
11.5.1 Company Overview
11.5.2 Product Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.6 BioTek Instruments, Inc.
11.6.1 Company Overview
11.6.2 Product Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 Danaher
11.7.1 Overview
11.7.2 Product Overview
11.7.3 Financials
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 Merck KGaA
11.8.1 Overview
11.8.2 Product Overview
11.8.3 Financials
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.9 Thermo Fisher Scientific Inc.
11.9.1 Overview
11.9.2 Product Overview
11.9.3 Financials
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.10 Others
Chapter 12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEO’s View Point
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Prediction of EMEA Cell Counting Market
Chapter 13 Appendix
LIST OF TABLES
Table 1 EMEA Cell Counting Industry Synopsis, 2017 – 2023
Table 2 EMEA Cell Counting Market Estimates and Forecast, 2017 – 2023, (USD Million)
Table 3 EMEA Cell Counting Market by Region, 2017 – 2023, (USD Million)
Table 4 EMEA Cell Counting Market by Product, 2017 – 2023, (USD Million)
Table 5 EMEA Cell Counting Market by Application, 2017 – 2023, (USD Million)
Table 6 EMEA Cell Counting Market by End Users, 2017 – 2023, (USD Million)
Table 7 EMEA Cell Counting Market by Product, 2017 – 2023, (USD Million)
Table 8 EMEA Cell Counting Market by Application, 2017 – 2023, (USD Million)
Table 9 EMEA Cell Counting Market by End Users, 2017 – 2023, (USD Million)
Table 10 Europe Cell Counting Market by Product, 2017 – 2023, (USD Million)
Table 11 Europe Cell Counting Market by Application, 2017 – 2023, (USD Million)
Table 12 Europe Cell Counting Market by End Users, 2017 – 2023, (USD Million)
Table 13 Western Europe Cell Counting Market by Product, 2017 – 2023, (USD Million)
Table 14 Western Europe Cell Counting Market by Application, 2017 – 2023, (USD Million)
Table 15 Western Europe Cell Counting Market by End Users, 2017 – 2023, (USD Million)
Table 16 Eastern Europe Cell Counting Market by Product, 2017 – 2023, (USD Million)
Table 17 Eastern Europe Cell Counting Market by Application, 2017 – 2023, (USD Million)
Table 18 Eastern Europe Cell Counting Market by End Users, 2017 – 2023, (USD Million)
Table 19 Asia Pacific Cell Counting Market by Product, 2017 – 2023, (USD Million)
Table 20 Asia Pacific Cell Counting Market by Application, 2017 – 2023, (USD Million)
Table 21 Asia Pacific Cell Counting Market by End Users, 2017 – 2023, (USD Million)
Table 22 Middle East & Africa Cell Counting Market by Product, 2017 – 2023, (USD Million)
Table 23 Middle East & Africa Cell Counting Market by Application, 2017 – 2023, (USD Million)
Table 24 Middle East & Africa Cell Counting Market by End Users, 2017 – 2023, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for EMEA Cell Counting Market
Figure 3 Market Dynamics for EMEA Cell Counting Market
Figure 4 EMEA Cell Counting Market Share, by Product 2016
Figure 5 EMEA Cell Counting Market Share, by Application, 2016
Figure 6 EMEA Cell Counting Market Share, by End Users, 2016
Figure 7 EMEA Cell Counting Market Share, by Region, 2016
Figure 8 EMEA Cell Counting Market Share, by Country, 2016
Figure 9 Europe Cell Counting Market Share, by Country, 2016
Figure 10 Asia Pacific Cell Counting Market Share, by Country, 2016
Figure 11 Middle East & Africa Cell Counting Market Share, by Country, 2016
Figure 12 EMEA Cell Counting Market: Company Share Analysis, 2016 (%)
Figure 13 Bio-Rad Laboratories Inc.: Key Financials
Figure 14 Bio-Rad Laboratories Inc.: Segmental Revenue
Figure 15 Bio-Rad Laboratories Inc.: Geographical Revenue
Figure 16 General Electric Company: Product UK Ltd: Key Financials
Figure 17 General Electric Company: Product UK Ltd: Segmental Revenue
Figure 18 General Electric Company: Product UK Ltd: Geographical Revenue
Figure 19 Agilent Technologies: Key Financials
Figure 20 Agilent Technologies: Segmental Revenue
Figure 21 Agilent Technologies: Geographical Revenue
Figure 22 PerkinElmer Inc.: Key Financials
Figure 23 PerkinElmer Inc.: Segmental Revenue
Figure 24 PerkinElmer Inc.: Geographical Revenue
Figure 25 Tecan Trading AG: Key Financials
Figure 26 Tecan Trading AG: Segmental Revenue
Figure 27 Tecan Trading AG: Geographical Revenue
Figure 28 BioTek Instruments, Inc.: Key Financials
Figure 29 BioTek Instruments, Inc.: Segmental Revenue
Figure 30 BioTek Instruments, Inc.: Geographical Revenue
Figure 31 Danaher: Key Financials
Figure 32 Danaher: Segmental Revenue
Figure 33 Danaher: Geographical Revenue
Figure 34 Merck KGaA: Key Financials
Figure 35 Merck KGaA: Segmental Revenue
Figure 36 Merck KGaA: Geographical Revenue
Figure 37 Thermo Fisher Scientific Inc.: Key Financials
Figure 38 Thermo Fisher Scientific Inc.: Segmental Revenue
Figure 39 Thermo Fisher Scientific Inc.: Geographical Revenue
